World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
97
Citations
33455
World Ranking
826
National Ranking
466

Medicine

D-Index
98
Citations
33619
World Ranking
8950
National Ranking
4605

Karl Erik Hellström publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Karl Erik Hellström sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 362 publications — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Karl Erik Hellström D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Karl Erik Hellström sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 97 D-Index — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Karl Erik Hellström is affiliated with the University of Washington in the United States. Their research primarily focuses on the fields of medicine and immunology and microbiology, with published work spanning key subfields such as oncology, immunology, and radiology, nuclear medicine, and imaging.

Their work reflects a concentration on several major topics within biomedical research, including immunotherapy and immune responses, cancer immunotherapy and biomarkers, monoclonal and polyclonal antibodies research, and CAR-T cell therapy research.

Hellström has contributed scholarly articles to peer-reviewed journals, including publication in the Journal of Immunotherapy. A notable recent paper published in 2021 is titled "Antibodies to EGF Receptor Family Members Can Upregulate Tumor Immunity," appearing in the Journal of Immunotherapy.

The scientist collaborates frequently with a group of coauthors, including Min Dai, Ingegerd Hellström, Yuen Yee Yip, and George J. Todaro. Among these, Min Dai and Ingegerd Hellström have been involved in multiple joint publications, indicating sustained research partnerships.

  • Antibodies to EGF Receptor Family Members Can Upregulate Tumor Immunity, 2021, Journal of Immunotherapy

  • Min Dai
  • Ingegerd Hellström
  • Yuen Yee Yip
  • George J. Todaro

  • Journal of Immunotherapy

  • Medicine
  • Immunology and Microbiology

  • Oncology
  • Immunology
  • Radiology, Nuclear Medicine and Imaging

  • Immunotherapy and Immune Responses
  • Cancer Immunotherapy and Biomarkers
  • Monoclonal and Polyclonal Antibodies Research
  • CAR-T cell therapy research

Best Publications

  • Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4

    Lieping Chen;Stephanie Ashe;William A. Brady;Ingegerd Hellström

  • Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host.

    George Klein;Hans Olof Sjögren;Eva Klein;Karl Erik Hellström

  • Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors

    Ignacio Melero;Walter W. Shuford;Stephanie Ashe Newby;Alejandro Aruffo

  • Suggestive evidence that the "blocking antibodies" of tumor-bearing individuals may be antigen--antibody complexes

    H. O. Sjögren;I. Hellström;S. C. Bansal;K. E. Hellström

  • Lymphocyte-Mediated Cytotoxicity And Blocking Serum Activity To Tumor Antigens

    Karl Erik Hellström;Ingegerd Hellström

  • Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity

    Lieping Chen;Patrick McGowan;Stephanie Ashe;Janet Johnston

  • Cellular immunity against tumor antigens.

    Karl Erik Hellström;Ingegerd Hellström

  • Blocking of cell-mediated tumor immunity by sera from patients with growing neoplasms.

    Ingegerd Hellström;Hans Olov Sjögren;Glenn Warner;Karl Erik Hellström

  • Chimeric mouse-human IgG1 antibody that can mediate lysis of cancer cells.

    A Y Liu;R R Robinson;K E Hellström;E D Murray

  • Cellular and humoral immunity to different types of human neoplasms

    I Hellstrom;K E Hellstrom;G E Pierce;J P S Yang

  • Costimulation of T cells for tumor immunity

    Lieping Chen;Peter S. Linsley;Karl Erik Hellström

  • SOLUBLE MEMBER(S) OF THE MESOTHELIN/MEGAKARYOCYTE POTENTIATING FACTOR FAMILY ARE DETECTABLE IN SERA FROM PATIENTS WITH OVARIAN CARCINOMA

    Nathalie Scholler;Ning Fu;Yi Yang;Zhengmao Ye

  • Studies on cellular immunity and its serum mediated inhibition in Moloney-virus-induced mouse sarcomas.

    Ingegerd Hellström;Karl Erik Hellström

  • Imaging of Melanoma with I-131-Labeled Monoclonal Antibodies

    Steven M. Larson;Joseph P. Brown;Peter W. Wright;Jorge A. Carrasquillo

  • Human melanoma-associated antigen p97 is structurally and functionally related to transferrin

    Joseph P. Brown;Rodney M. Hewick;Ingegerd Hellström;Karl Erik Hellström

  • Demonstration of cell-bound and humoral immunity against neuroblastoma cells.

    Ingegerd E. Hellstrom;Karl Erik Hellstrom;George E. Pierce;Alexander H. Bill

  • Structural characterization of human melanoma-associated antigen p97 with monoclonal antibodies.

    J P Brown;K Nishiyama;I Hellström;K E Hellström

  • Human papillomavirus type 16 nucleoprotein E7 is a tumor rejection antigen.

    Lieping Chen;Elaine Kinney Thomas;Shiu Lok Hu;Ingegerd Hellström

  • Localization of 131I-labeled p97-specific Fab fragments in human melanoma as a basis for radiotherapy.

    S M Larson;J A Carrasquillo;K A Krohn;J P Brown

  • AMPLIFICATION OF TUMOR IMMUNITY BY GENE TRANSFER OF THE CO-STIMULATORY 4-1BB LIGAND : SYNERGY WITH THE CD28 CO-STIMULATORY PATHWAY

    Ignacio Melero;Nathan Bach;Karl Erik Hellström;Alejandro Aruffo

  • Highly tumor-reactive, internalizing, mouse monoclonal antibodies to Le(y)-related cell surface antigens.

    I Hellström;H J Garrigues;U Garrigues;K E Hellström

Frequent Co-Authors

Ingegerd Hellström
Ingegerd Hellström University of Washington
Lieping Chen
Lieping Chen Yale University
Irwin D. Bernstein
Irwin D. Bernstein Fred Hutchinson Cancer Research Center
Peter D. Senter
Peter D. Senter Seattle Genetics (United States)
Alejandro Aruffo
Alejandro Aruffo Syngenta (United States)
Gerald T. Nepom
Gerald T. Nepom Virginia Mason Medical Center
Kenneth A. Krohn
Kenneth A. Krohn Oregon Health & Science University
Elizabeth M. Swisher
Elizabeth M. Swisher University of Washington
Jeffrey A. Ledbetter
Jeffrey A. Ledbetter University of Washington
Jürgen Bajorath
Jürgen Bajorath University of Bonn

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those studying Immunology in the USA, expanding your qualifications through related degrees can open diverse career opportunities. Nursing specializations, such as psychiatric mental health, often complement immunology knowledge. Exploring the cheapest pmhnp certificate programs is a practical step for professionals seeking cost-effective education pathways.

Advanced practice roles like Doctor of Nursing Practice (DNP) graduates can expect competitive salaries. If you’re considering your earning potential, knowing how much do dnps make across different states is essential for informed career planning.

Shifting specialties within nursing can also broaden your impact. For instance, transitioning from a Family Nurse Practitioner (FNP) to an Acute Care Nurse Practitioner (ACNP) role requires specific training. Detailed information about acnp programs can guide those interested in acute care settings.

Moreover, accelerated paths like accelerated np programs offer efficient routes to obtaining nurse practitioner qualifications. These programs are ideal for professionals looking to advance quickly while building on their immunology background.

Best Scientists Citing Karl Erik Hellström

Trending Scientists

Recently Published Articles